Enovis Corp ENOV 深 沪
等待开盘 10-01 09:30:00 美东时间
18.27
-0.190
-1.03%
华盛通- 最 高18.70
- 今 开18.51
- 成交量 194.30万股
- 最 低 18.08
- 昨 收 18.46
- 总市值 10.54亿
- 52周最高 34.28
- 市盈率 静 --
- 换手率 3.37%
- 52周最低 17.30
- 委 比 27.80%
- 总股本 5766.95万
- 历史最高 176.11
- 量 比 1.35
- 振 幅 3.36%
- 历史最低 -13.31
- 每 手 1
- 风险率 3.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nyxoah names new CEO
Nyxoah (NYXH) appointed Liam Kelly as chief executive officer, effective October 1, 2026, succeeding Olivier Taelman. The leadership change comes as Nyxoah transitions toward a U.S.-focused commercial...
09-29 04:49
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Nyxoah appoints Liam Kelly as Chief Executive Officer, effective October 1, 2026, to strengthen its U.S. presence following FDA approval and the launch of Genio. Kelly brings over 25 years of leadership experience, previously serving as CEO and Chairman of Teleflex Incorporated. Nyxoah focuses on developing innovative solutions for Obstructive Sleep Apnea (OSA), with Genio as its lead product. The appointment underscores the company's strategic s...
09-28 20:30
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
Company expands its support from the American Joint Replacement Registry to include the Shoulder & Elbow Registry ROSEMONT, Ill., Sept. 22, 2026 /PRNewswire/ -- The American Academy of Ortho...
09-23 00:02
美股周涨跌榜 | 生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周内大涨26%
生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周涨26%！受比特币反弹及云业务双重催化；Strive涨近25%，四天增持约1,800枚比特币>>
09-05 10:16
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.
09-02 20:50
Enovis to acquire eCential Robotics
Enovis (ENOV) has agreed to acquire eCential Robotics for an upfront enterprise value of €155M. The deal corresponds to cash consideration of approximately €176M to be paid to eCential Robotics’ share...
09-01 19:02
Enovis Enters Into Binding Offer To Acquire eCential Robotics For Upfront Enterprise Value Of €155 Mln
Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room. Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub. Dallas, TX, Sep...
09-01 18:37
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
Enovis Corporation has agreed to acquire eCential Robotics for €176 million, enhancing its ASTRA platform with robotic automation to improve surgical precision and efficiency. The deal, expected to close by year-end 2026, will integrate eCential's expertise into Enovis' technology ecosystem, creating a robotics center of excellence in Grenoble, France. Enovis aims to boost patient outcomes and streamline workflows in the operating room through th...
09-01 10:30
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
